IXIARO JE vaccine
Showing 1 - 25 of 8,411
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Syracuse (CYD Dengue Vaccine, Japanese Encephalitis Vaccine)
Completed
- Dengue
- +2 more
- CYD Dengue Vaccine
- Japanese Encephalitis Vaccine
-
Syracuse, New York(unnamed)
Mar 15, 2022
Japanese Encephalitis, Varicella Trial in Muntinlupa City (JE-CV Vaccine, Varicella Vaccine)
Completed
- Japanese Encephalitis
- Varicella
- JE-CV Vaccine
- Varicella Vaccine
-
Muntinlupa City, Philippines(unnamed)
Mar 21, 2022
Iron Deficiency Anemia Trial (Iron-fortified cookies, Japanese encephalitis (JE) vaccine, Typhoid Vi polysaccharide (Vi-PS)
Not yet recruiting
- Iron Deficiency Anemia
- Iron-fortified cookies
- +3 more
- (no location specified)
Aug 30, 2023
Encephalitis Trial in Muntinlupa, Manila (IC51 Japanese Encephalitis, Havrix®720, Prevnar)
Completed
- Encephalitis
- IC51 Japanese Encephalitis
- +2 more
-
Muntinlupa, Filinvest Corporate City, Philippines
- +1 more
Jul 5, 2021
Japanese Encephalitis Trial in Liverpool (IMOJEV)
Enrolling by invitation
- Japanese Encephalitis
- IMOJEV
-
Liverpool, United KingdomLiverpool University Hospitals NHS Foundation Trust
Sep 28, 2021
Zika Virus Infection Trial in Silver Spring (IXIARO, Placebo, YF Vax 17D Strain)
Completed
- Zika Virus Infection
- IXIARO
- +3 more
-
Silver Spring, MarylandWalter Reed Army Institute of Research - Clinical Trials Center
Sep 3, 2020
Encephalitis, Japanese Trial (Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine)
Completed
- Encephalitis, Japanese
- Live Attenuated Japanese Encephalitis SA-14-14-2 Vaccine
- (no location specified)
Sep 24, 2020
Japanese Encephalitis, Vaccine Preventable Disease, Vaccine Reaction Trial in Lishui, Quzhou, Wenzhou (Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis
- +2 more
- Japanese Encephalitis Vaccine (Vero Cell), Inactivated;
- No prospective interventions
-
Lishui, Zhejiang, China
- +2 more
Nov 13, 2022
SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza
Active, not recruiting
- SARS-CoV-2 Infection
- COVID-19
- SARS-CoV-2 rS/Matrix M1-Adjuvant
- +2 more
-
Belfast, Antrim, United Kingdom
- +32 more
Oct 19, 2022
Japanese Encephalitis Trial in Homagama, Kolonnawa, Moratuwa (Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV))
Completed
- Japanese Encephalitis
- Live, Attenuated Japanese Encephalitis SA 14-14-2 Vaccine (LJEV)
-
Homagama, District Of Colombo, Sri Lanka
- +2 more
Mar 18, 2020
Japanese Encephalitis Trial in Australia, Germany, United States (Blood draw, IC51 has given in the parent study IC51-322)
Completed
- Japanese Encephalitis
- Blood draw
- IC51 has given in the parent study IC51-322
-
Tampa, Florida
- +4 more
Mar 17, 2020
Japanese Encephalitis Virus Disease Trial in Hohhot (Japanese Encephalitis Vaccine produced by IMBCAMS, Japanese Encephalitis
Active, not recruiting
- Japanese Encephalitis Virus Disease
- Japanese Encephalitis Vaccine produced by IMBCAMS
- Japanese Encephalitis Vaccine produced by Liaoning Chenda
-
Hohhot, Inner Mongolia Autonomous Region, ChinaDisease prevention and control center of Inner Mongolia autonomo
Mar 8, 2022
Japanese Encephalitis Vaccine Trial in Vienna (IXIARO®- Japanese Encephalitis vaccine)
Unknown status
- Japanese Encephalitis Vaccine
- IXIARO®- Japanese Encephalitis vaccine
-
Vienna, Austria
- +1 more
May 29, 2019
Japanese Encephalitis Trial in Hoa Binh (Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®))
Completed
- Japanese Encephalitis
- Live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®)
-
Hoa Binh, VietnamPreventive Medicine Centre of Hoa Binh Province
Mar 21, 2022
Japanese Encephalitis Trial in Gyeonggi-do, Seoul, Wonju (IMOJEV)
Completed
- Japanese Encephalitis
- IMOJEV
-
Gyeonggi-do, Korea, Republic of
- +7 more
Mar 21, 2022
Microbial Colonization Trial in Wageningen (WholeFiber, Kombucha, Maltodextrin DE19/21)
Not yet recruiting
- Microbial Colonization
- WholeFiber
- +2 more
-
Wageningen, Gelderland, NetherlandsStichting Wageningen Research
Jun 9, 2023
Healthy Volunteers Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rVSV-Zebov GP vaccine)
Active, not recruiting
- Healthy Volunteers
- rVSV-Zebov GP vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 7, 2023
Lung Transplant Recipient, SARS-CoV-2, Immunosuppression Trial (mRNA-1273 (Moderna COVID-19 vaccine))
Active, not recruiting
- Lung Transplant Recipient
- +2 more
- mRNA-1273 (Moderna COVID-19 vaccine)
-
Los Angeles, CaliforniaUCLA Clinical Translational Research Center
Dec 13, 2022
Individuals With and Without Immune Deficiencies and
Recruiting
- Immunodeficiencies
- Immune Dysregulations
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 6, 2023
SARS-CoV Infection Trial in India (BBV154 Vaccine, Placebo)
Completed
- SARS-CoV Infection
- BBV154 Vaccine
- Placebo
-
Patna, Bihar, India
- +3 more
Aug 17, 2022
Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)
Completed
- Ebola Virus
- cAd3-EBO S vaccine
-
Kampala, UgandaMakerere University-Walter Reed Project
Nov 10, 2022
COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)
Not yet recruiting
- COPD Exacerbation Acute
- CUVITRU - Ig subcutaneous human 20%
- Standard Medical Therapy
-
Rochester, New York
- +2 more
Feb 28, 2023
Psychology, Social, Inflammation, Defeat, Social Trial in Chapel Hill (Influenza vaccine, Placebo)
Recruiting
- Psychology, Social
- +3 more
- Influenza vaccine
- Placebo
-
Chapel Hill, North Carolina
- +1 more
Dec 8, 2022